ISRG vs BSX
ISRG and BSX side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ISRGIntuitive Surgical, Inc. | BSXBOSTON SCIENTIFIC CORPORATION |
|---|---|---|
| Market cap | $135.53B | $63.13B |
| P/E (TTM) | 44.0 | 17.6 |
| P/B | 7.46 | 2.53 |
| P/S | 13.5x | 3.1x |
| Revenue | $11.03B(TTM) | $21.00B(TTM) |
| Revenue growth (YoY) | 20.5% | 19.9% |
| Net income | $3.14B(TTM) | $3.67B(TTM) |
| Earnings growth (YoY) | 23.0% | 56.7% |
| EPS, diluted | $8.72(TTM) | $2.47(TTM) |
| EBIT margin | 29.3% | 18.0% |
| ROE | 15.7% | 11.6% |
| ROIC | — | 10.0% |
| Piotroski F | — | 8/9 |
| 1y total return | -11.4% | -55.8% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ISRG frente a BSX
| Métrica | ISRG | BSX |
|---|---|---|
| Valor final | $54.3K | $19.2K |
| Retorno total | +443.3% | +92.1% |
| CAGR | +17.8% | +6.5% |
| Volatilidad | 32.7% | 27.4% |
| Sharpe | 0.54 | 0.22 |
| Sortino | 0.78 | 0.30 |
| Caída máxima | -49.9% | -60.6% |
Basado en 2600 días de negociación comunes, 2016-05-16 → 2026-09-17 · tasa libre de riesgo 4.12% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)